Edition:
United Kingdom

People: Concert Pharmaceuticals Inc (CNCE.OQ)

CNCE.OQ on NASDAQ Stock Exchange Global Market

11.05USD
9:00pm BST
Change (% chg)

$-0.16 (-1.43%)
Prev Close
$11.21
Open
$11.25
Day's High
$11.49
Day's Low
$11.04
Volume
53,653
Avg. Vol
78,061
52-wk High
$20.19
52-wk Low
$9.23

Stuart, Nancy 

Ms. Nancy Stuart is the Chief Operating Officer of Concert Pharmaceuticals Inc. Ms. Stuart has served as our Chief Operating Officer since October 2007 and was our Senior Vice President, Corporate Strategy and Operations from July 2006 to October 2007. Prior to joining Concert, Ms. Stuart held various business operations and business development positions at Amgen Inc., a biopharmaceutical company, Kinetix Pharmaceuticals, Inc., a pharmaceutical company subsequently acquired by Amgen, Scion Pharmaceuticals, Inc., a pharmaceutical company, Vertex Pharmaceuticals Incorporated and Genzyme Corporation. Ms. Stuart holds a B.S. from the University of Michigan and an M.B.A. from the Simmons College Graduate School of Management.

Basic Compensation

Total Annual Compensation, USD 412,186
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,495,840
Fiscal Year Total, USD 1,908,030

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Aldrich

205,613

Roger Tung

4,607,850

Marc Becker

2,450,530

Nancy Stuart

1,908,030

James Cassella

1,960,240

Thomas Auchincloss

205,613
As Of  31 Dec 2018